Publications by authors named "Dahong Yu"

Claim this Profile
F
Flavin-Containing Monooxygenase 3 Genetic Variants and Possible Susceptibility to Coronary Heart Disease Among Han Chinese With Type 2 Diabetes.
Yuanmin Mao, Nan Gu, Xiaowei Ma, Yuxin Wang, Na Yu, Dahong Yu

Int J Endocrinol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, Lori Ann Cox, Anindita Banerjee, Dahong Yu

J Am Acad Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Sirtuin 1 Gene Polymorphisms with the Risk of Coronary Heart Disease in Chinese Han Patients with Type 2 Diabetes Mellitus.
Yuxin Wang, Linchao Tong, Nan Gu, Xiaowei Ma, Difei Lu, Dahong Yu, Na Yu

J Diabetes Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial.
Seth B Forman, David M Pariser, Yves Poulin, Michael S Vincent, Steven A Gilbert, Dahong Yu

J Invest Dermatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Dahong Yu

N Engl J Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.
William J Sandborn, Julian Panés, Haiying Zhang, Dahong Yu, Wojciech Niezychowski, Chinyu Su

Gastroenterology· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of subcutaneous methylnaltrexone in the treatment of opioid-induced constipation: a responder post hoc analysis.
Edward Michna, Arnold J Weil, Marc Duerden, Seth Schulman, Wenjin Wang, Dahong Yu

Pain Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
Steven E Kahn, Steven M Haffner, Giancarlo Viberti, William H Herman, John M Lachin, Dahong Yu

Diabetes Care· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
Steven E Kahn, Bernard Zinman, John M Lachin, Steven M Haffner, William H Herman, Dahong Yu

Diabetes Care· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.
Priscilla Hollander, Dahong Yu, Hubert S Chou

Arch Intern Med· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy.
Dahong Yu, Susan J Murdoch, Shamik J Parikh, Santica M Marcovina, Alexander Cobitz

Diab Vasc Dis Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Steven E Kahn, Bernard Zinman, Steven M Haffner, M Colleen O'Neill, Barbara G Kravitz, Dahong Yu

Diabetes· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfection of the sodium/glucose cotransporter into colon mucosa: a novel treatment for short bowel syndrome.
Philip Y Pearson, Dahong Yu, Marshall Z Schwartz

J Pediatr Surg· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis